At the time of writing, Novo Nordisk ADR [NVO] stock is trading at $50.26, up 2.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NVO shares have gain 3.71% over the last week, with a monthly amount drifted -11.30%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, HSBC Securities upgraded its rating to Buy on October 01, 2025. On September 29, 2025, downgrade downgraded it’s rating to Underweight but maintained its price target of $47 on the stock. Berenberg upgraded its rating to a Buy. Rothschild & Co Redburn upgraded its rating to a Buy. Bernstein upgraded its rating to Outperform for this stock on September 09, 2025. In a note dated August 13, 2025, BNP Paribas Exane upgraded an Neutral rating on this stock but restated the target price of $54.
For the past year, the stock price of Novo Nordisk ADR fluctuated between $45.05 and $112.52. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Novo Nordisk ADR [NYSE: NVO] shares were valued at $50.26 at the most recent close of the market. An investor can expect a potential return of 9.43% based on the average NVO price forecast.
Analyzing the NVO fundamentals
According to Novo Nordisk ADR [NYSE:NVO], the company’s sales were 46.69B for trailing twelve months, which represents an 11.80% jump. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.46%, Pretax Profit Margin comes in at 0.45%, and Net Profit Margin reading is 0.36%. To continue investigating profitability, this company’s Return on Assets is posted at 0.23, Equity is 0.78 and Total Capital is 0.52. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.59.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 49.58 points at the first support level, and at 48.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.69, and for the 2nd resistance point, it is at 51.11.
Ratios To Look Out For
It is important to note that Novo Nordisk ADR [NYSE:NVO] has a current ratio of 0.78. In addition, the Quick Ratio stands at 0.57 and the Cash Ratio stands at 0.09. Considering the valuation of this stock, the price to sales ratio is 3.63, the price to book ratio is 8.35 and price to earnings (TTM) ratio is 14.64.
Transactions by insiders
Recent insider trading involved Novo Nordisk A/S, 10% Owner, that happened on May 30 ’25 when 0.92 million shares were purchased.
